FNCH
Income statement / Annual
Last year (2023), Finch Therapeutics Group, Inc.'s total revenue was $107,000.00,
a decrease of 87.57% from the previous year.
In 2023, Finch Therapeutics Group, Inc.'s net income was -$74.75 M.
See Finch Therapeutics Group, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$107,000.00
|
$861,000.00
|
$18.53 M
|
$7.72 M
|
$10.15 M
|
| Cost of Revenue |
$7.20 M |
$5.51 M |
$57.28 M |
$33.14 M |
$314,000.00 |
| Gross Profit |
-$7.09 M |
-$4.65 M |
-$38.75 M |
-$25.43 M |
$9.84 M |
| Gross Profit Ratio |
-66.28 |
-5.4 |
-2.09 |
-3.29 |
0.97 |
| Research and Development
Expenses |
$7.20 M
|
$57.89 M
|
$57.28 M
|
$33.14 M
|
$23.54 M
|
| General & Administrative
Expenses |
$26.91 M
|
$38.09 M
|
$21.24 M
|
$14.01 M
|
$7.44 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$26.91 M
|
$38.09 M
|
$21.24 M
|
$14.01 M
|
$7.44 M
|
| Other Expenses |
$0.00 |
$947,000.00 |
$1.83 M |
$2,000.00 |
$40,000.00 |
| Operating Expenses |
$32.59 M |
$95.98 M |
$78.52 M |
$47.16 M |
$30.98 M |
| Cost And Expenses |
$34.11 M |
$95.98 M |
$78.52 M |
$47.16 M |
$31.30 M |
| Interest Income |
$1.57 M |
$252,000.00 |
$22,000.00 |
$106,000.00 |
$488,000.00 |
| Interest Expense |
$0.00 |
$35.44 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.52 M
|
$5.51 M
|
$2.30 M
|
$790,000.00
|
$482,000.00
|
| EBITDA |
-$32.48 M
|
-$82.69 M
|
-$57.68 M
|
-$38.65 M
|
-$20.66 M
|
| EBITDA Ratio |
-303.57 |
-86.7 |
-3.24 |
-5 |
-2.02 |
| Operating Income Ratio
|
-317.78
|
-134.25
|
-3.24
|
-5.11
|
-2.08
|
| Total Other
Income/Expenses Net |
-$44.21 M
|
$947,000.00
|
$1.83 M
|
$95,000.00
|
$388,000.00
|
| Income Before Tax |
-$78.22 M |
-$114.65 M |
-$58.16 M |
-$39.34 M |
-$20.75 M |
| Income Before Tax Ratio
|
-730.98
|
-133.15
|
-3.14
|
-5.1
|
-2.04
|
| Income Tax Expense |
-$3.46 M |
-$947,000.00 |
-$2.30 M |
-$93,000.00 |
-$348,000.00 |
| Net Income |
-$74.75 M |
-$113.70 M |
-$55.86 M |
-$39.25 M |
-$20.41 M |
| Net Income Ratio |
-698.64 |
-132.05 |
-3.01 |
-5.08 |
-2.01 |
| EPS |
-46.59 |
-71.52 |
-35.27 |
-24.39 |
-12.68 |
| EPS Diluted |
-46.59 |
-71.52 |
-35.27 |
-24.39 |
-12.68 |
| Weighted Average Shares
Out |
$1.60 M
|
$1.59 M
|
$1.58 M
|
$1.61 M
|
$1.61 M
|
| Weighted Average Shares
Out Diluted |
$1.60 M
|
$1.59 M
|
$1.58 M
|
$1.61 M
|
$1.61 M
|
| Link |
|
|
|
|
|
